227 related articles for article (PubMed ID: 35482806)
1. Non-canonical genomic driver mutations of urethane carcinogenesis.
Li S; Counter CM
PLoS One; 2022; 17(4):e0267147. PubMed ID: 35482806
[TBL] [Abstract][Full Text] [Related]
2. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
[TBL] [Abstract][Full Text] [Related]
3. Signaling levels mold the RAS mutation tropism of urethane.
Li S; Counter CM
Elife; 2021 May; 10():. PubMed ID: 33998997
[TBL] [Abstract][Full Text] [Related]
4. Capturing the primordial Kras mutation initiating urethane carcinogenesis.
Li S; MacAlpine DM; Counter CM
Nat Commun; 2020 Apr; 11(1):1800. PubMed ID: 32286309
[TBL] [Abstract][Full Text] [Related]
5. Decreased tumorigenesis in mice with a Kras point mutation at C118.
Huang L; Carney J; Cardona DM; Counter CM
Nat Commun; 2014 Nov; 5():5410. PubMed ID: 25394415
[TBL] [Abstract][Full Text] [Related]
6. Rare codons capacitate Kras-driven de novo tumorigenesis.
Pershing NL; Lampson BL; Belsky JA; Kaltenbrun E; MacAlpine DM; Counter CM
J Clin Invest; 2015 Jan; 125(1):222-33. PubMed ID: 25437878
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Sprouty 2 in mouse lung epithelium inhibits urethane-induced tumorigenesis.
Minowada G; Miller YE
Am J Respir Cell Mol Biol; 2009 Jan; 40(1):31-7. PubMed ID: 18635814
[TBL] [Abstract][Full Text] [Related]
8. Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung.
Maeda Y; Tsuchiya T; Hao H; Tompkins DH; Xu Y; Mucenski ML; Du L; Keiser AR; Fukazawa T; Naomoto Y; Nagayasu T; Whitsett JA
J Clin Invest; 2012 Dec; 122(12):4388-400. PubMed ID: 23143308
[TBL] [Abstract][Full Text] [Related]
9. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.
Fujimoto J; Nunomura-Nakamura S; Liu Y; Lang W; McDowell T; Jakubek Y; Ezzeddine D; Kapere Ochieng J; Petersen J; Davies G; Fukuoka J; Wistuba II; Ehli E; Fowler J; Scheet P; Kadara H
Int J Cancer; 2017 Oct; 141(8):1589-1599. PubMed ID: 28653505
[TBL] [Abstract][Full Text] [Related]
10. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice.
Weyandt JD; Carney JM; Pavlisko EN; Xu M; Counter CM
PLoS One; 2016; 11(12):e0167205. PubMed ID: 27911940
[TBL] [Abstract][Full Text] [Related]
11. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Green S; Trejo CL; McMahon M
Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
[TBL] [Abstract][Full Text] [Related]
12. Genomic landscape of chemical-induced lung tumors under Nrf2 different expression levels.
Satoh H; Arai Y; Furukawa E; Moriguchi T; Hama N; Urushidate T; Totoki Y; Kato M; Ohe Y; Yamamoto M; Shibata T
Carcinogenesis; 2022 Aug; 43(7):613-623. PubMed ID: 35561328
[TBL] [Abstract][Full Text] [Related]
13. Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
To MD; Wong CE; Karnezis AN; Del Rosario R; Di Lauro R; Balmain A
Nat Genet; 2008 Oct; 40(10):1240-4. PubMed ID: 18758463
[TBL] [Abstract][Full Text] [Related]
14. Oncogene-induced senescence underlies the mutual exclusive nature of oncogenic KRAS and BRAF.
Cisowski J; Sayin VI; Liu M; Karlsson C; Bergo MO
Oncogene; 2016 Mar; 35(10):1328-33. PubMed ID: 26028035
[TBL] [Abstract][Full Text] [Related]
15. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
[TBL] [Abstract][Full Text] [Related]
16. Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma.
Lee CL; Mowery YM; Daniel AR; Zhang D; Sibley AB; Delaney JR; Wisdom AJ; Qin X; Wang X; Caraballo I; Gresham J; Luo L; Van Mater D; Owzar K; Kirsch DG
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31112524
[TBL] [Abstract][Full Text] [Related]
17. Carcinogen-specific mutations in preferred Ras-Raf pathway oncogenes directed by strand bias.
Keller RR; Gestl SA; Lu AQ; Hoke A; Feith DJ; Gunther EJ
Carcinogenesis; 2016 Aug; 37(8):810-816. PubMed ID: 27207659
[TBL] [Abstract][Full Text] [Related]
18. KRAS
Zhou ZW; Ambrogio C; Bera AK; Li Q; Li XX; Li L; Son J; Gondi S; Li J; Campbell E; Jin H; Okoro JJ; Xu CX; Janne PA; Westover KD
Cancer Res; 2020 Sep; 80(17):3719-3731. PubMed ID: 32605999
[TBL] [Abstract][Full Text] [Related]
19. EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma.
Chalela R; González-García JG; Khilzi K; Curull V; Sánchez-Font A; Longarón R; Rodrigo-Calvo MT; Martín-Ontiyuelo C; Gea J; Bellosillo B
Pathol Oncol Res; 2021; 27():598292. PubMed ID: 34257550
[TBL] [Abstract][Full Text] [Related]
20. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS
Mol Carcinog; 1996 Dec; 17(4):217-23. PubMed ID: 8989915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
